Abstract
Human pluripotent stem cell-derived cardiomyocytes (hPSC-CM) are being investigated as a new source of cardiac cells for drug safety assessment. We developed a novel scalable high content microscopy-based method for the detection of cell death in hPSC-CM that can serve for future predictive in vitro cardio-toxicological screens. Using rat neonatal ventricular cardiomyocytes (RVNC) or hPSC-CM, assays for nuclear remodelling, mitochondrial status, apoptosis and necrosis were designed using a combination of fluorescent dyes and antibodies on an automated microscopy platform. This allowed the observation of a chelerythrine-induced concentration-dependent apoptosis to necrosis switch and time-dependent progression of early apoptotic cells towards a necrotic-like phenotype. Susceptibility of hPSC-CM to chelerythrine-stimulated apoptosis varied with time after differentiation, but at most time points, hPSC-CM were more resistant than RVNC. This simple and scalable humanized high-content assay generates accurate cardiotoxicity profiles that can serve as a base for further assessment of cardioprotective strategies and drug safety. © 2012 The Author(s).
Author supplied keywords
Cite
CITATION STYLE
Mioulane, M., Foldes, G., Ali, N. N., Schneider, M. D., & Harding, S. E. (2012). Development of high content imaging methods for cell death detection in human pluripotent stem cell-derived cardiomyocytes. Journal of Cardiovascular Translational Research, 5(5), 593–604. https://doi.org/10.1007/s12265-012-9396-1
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.